PTEN permits acute increases in D3‐phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt

Phosphoinositide 3‐kinase (PI3K) is important in TCR signaling. PI3K generates phosphatidylinositol 3, 4, 5‐trisphosphate (PI‐3,4,5‐P3), which regulates membrane localization and/or activity of multiple signaling proteins. PTEN (phosphatase and tensin homologue deleted on chromosome 10) opposes PI3K, reversing this reaction. Maintaining the balance between these two enzymes is important for normal T cell function. Here we use the PTEN‐null Jurkat T cell line to address the role of PTEN in modulating proximal and distal TCR‐signaling events. PTEN expression at levels that restored low basal Akt phosphorylation (an indicator of PI‐3,4,5‐P3 levels), but which were not themselves cytotoxic, had minimal effect on TCR‐stimulated activation of phospholipase Cγ1 and Ca2+ flux, but reduced the duration of extracellular signal‐regulated kinase (Erk) activation. Distal signaling events, including nuclear factor of activated T cells (NFAT) activation, CD69 expression and IL‐2 production, were all inhibited by PTEN expression. Notably, PTEN did not block TCR‐stimulated PI‐3,4,5‐P3 accumulation. The effect of PTEN on distal TCR signaling events was strongly correlated with the loss of the constitutive Akt activation and glycogen synthase kinase‐3 (GSK3) inhibition that is typical of Jurkat cells, and could be reversed by expression of activated Akt or pharmacologic inhibition of GSK3. These results suggest that PTEN acts in T cells primarily to control basal PI‐3,4,5‐P3 levels, rather than opposing PI3K acutely during TCR stimulation.

[1]  T. Mustelin,et al.  Inhibition of phosphatidylinositol 3-kinase blocks T cell antigen receptor/CD3-induced activation of the mitogen-activated kinase Erk2. , 1996, European journal of biochemistry.

[2]  Christoph W. Turck,et al.  Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3 , 1997, Science.

[3]  A. Weiss,et al.  The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[4]  S. Yamasaki,et al.  Genetic evidence for Shc requirement in TCR-induced c-Rel nuclear translocation and IL-2 expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Michael J. Parsons,et al.  Expression of Active Protein Kinase B in T Cells Perturbs Both T and B Cell Homeostasis and Promotes Inflammation1 , 2001, The Journal of Immunology.

[6]  A. Weiss,et al.  Induction of NF-κB by the Akt/PKB kinase , 1999, Current Biology.

[7]  J. Kaptein,et al.  Synergy between signal transduction pathways is obligatory for expression of c-fos in B and T cell lines: implication for c-fos control via surface immunoglobulin and T cell antigen receptors. , 1995, Immunobiology.

[8]  P. Schwartzberg,et al.  Deficiency of PTEN in Jurkat T Cells Causes Constitutive Localization of Itk to the Plasma Membrane and Hyperresponsiveness to CD3 Stimulation , 2000, Molecular and Cellular Biology.

[9]  A. Weiss,et al.  Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines , 2001, Nature Immunology.

[10]  T. Mustelin,et al.  The Tumor Suppressor PTEN Regulates T Cell Survival and Antigen Receptor Signaling by Acting as a Phosphatidylinositol 3-Phosphatase1 , 2000, The Journal of Immunology.

[11]  D. Kioussis,et al.  Vav1 Transduces T Cell Receptor Signals to the Activation of Phospholipase C-γ1 via Phosphoinositide 3-Kinase-dependent and -independent Pathways , 2002, The Journal of experimental medicine.

[12]  J W Sedat,et al.  Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. , 2000, Science.

[13]  J. Neal,et al.  Glycogen Synthase Kinase-3 Inhibits the DNA Binding Activity of NFATc* , 2001, The Journal of Biological Chemistry.

[14]  S. Bunnell,et al.  T Cell Receptor–initiated Calcium Release Is Uncoupled from Capacitative Calcium Entry in Itk-deficient T Cells , 1998, The Journal of experimental medicine.

[15]  P. Blumberg,et al.  RasGRP links T-cell receptor signaling to Ras. , 2000, Blood.

[16]  Kenneth M. Yamada,et al.  Shc and Fak Differentially Regulate Cell Motility and Directionality Modulated by Pten , 1999, The Journal of cell biology.

[17]  M. Gorospe,et al.  PTEN expression in PTEN-null leukaemic T cell lines leads to reduced proliferation via slowed cell cycle progression , 2003, Oncogene.

[18]  R. Aebersold,et al.  Activating and Inhibitory Mutations in Adjacent Tyrosines in the Kinase Domain of ZAP-70 (*) , 1995, The Journal of Biological Chemistry.

[19]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[20]  M. Raffeld,et al.  PTEN gene alterations in lymphoid neoplasms. , 1998, Blood.

[21]  K. Okkenhaug,et al.  Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice , 2002, Science.

[22]  T. Sasaki,et al.  T cell-specific loss of Pten leads to defects in central and peripheral tolerance. , 2001, Immunity.

[23]  J. Flores,et al.  Increased phosphoinositide 3‐kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  Tetsuo Yamazaki,et al.  T cell receptor ligation induces the formation of dynamically regulated signaling assemblies , 2002, The Journal of cell biology.

[25]  Michael J. Parsons,et al.  Negative Regulation of T Cell Proliferation and Interleukin 2 Production by the Serine Threonine Kinase Gsk-3 , 2000, The Journal of experimental medicine.

[26]  M. Seminario,et al.  Lipid phosphatases in the regulation of T cell activation: living up to their PTEN‐tial , 2003, Immunological reviews.

[27]  J. Woodgett,et al.  Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. , 1993, Oncogene.

[28]  S. Ward,et al.  Phosphoinositide 3-kinases in T lymphocyte activation. , 2001, Current opinion in immunology.

[29]  S. Ward,et al.  Evidence That SHIP-1 Contributes to Phosphatidylinositol 3,4,5-Trisphosphate Metabolism in T Lymphocytes and Can Regulate Novel Phosphoinositide 3-Kinase Effectors1 , 2002, The Journal of Immunology.

[30]  M. Farrar,et al.  Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells1 , 2004, The Journal of Immunology.

[31]  Tony Hunter,et al.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.

[32]  A. Weiss,et al.  It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. , 2002, Trends in immunology.

[33]  J. Imboden,et al.  Mutational analysis of CD28-mediated costimulation of Jun-N-terminal kinase and IL-2 production. , 1998, Journal of immunology.

[34]  W L Stanford,et al.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. , 2000, Science.

[35]  T. Franke,et al.  Phosphoinositide 3-Kinase Regulation of T Cell Receptor-mediated Interleukin-2 Gene Expression in Normal T Cells* , 1998, The Journal of Biological Chemistry.

[36]  J. Auwerx,et al.  Negative regulation of Jun/AP-1: conserved function of glycogen synthase kinase 3 and the Drosophila kinase shaggy. , 1993, Oncogene.

[37]  M. Montminy,et al.  CREB Is a Regulatory Target for the Protein Kinase Akt/PKB* , 1998, The Journal of Biological Chemistry.

[38]  P. Várnai,et al.  Phosphatidylinositol 3-Kinase-dependent Membrane Association of the Bruton’s Tyrosine Kinase Pleckstrin Homology Domain Visualized in Single Living Cells* , 1999, The Journal of Biological Chemistry.

[39]  Silvano Sozzani,et al.  Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation , 2000 .

[40]  J. Dixon,et al.  The PTEN Tumor Suppressor Protein Inhibits Tumor Necrosis Factor-induced Nuclear Factor κB Activity* , 2001, The Journal of Biological Chemistry.

[41]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.